ADAMTS13 and congenital thrombotic thrombocytopenic purpura: This condition is characterized by microangiopathic hemolytic anemia and thrombocytopenia, which can result from either an acquired deficiency of the ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) or through complement-mediated mechanisms.